Bridgewater Associates’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.89M | Buy |
26,750
+20,773
| +348% | +$1.12M | 0.01% | 725 |
|
|
2026
Q1 | $312K | Buy |
+5,977
| New | +$359K | ﹤0.01% | 946 |
|
|
2025
Q4 | – | Sell |
-41,146
| Closed | -$2.29M | – | 1175 |
|
|
2025
Q3 | $2.29M | Buy |
+41,146
| New | +$2.2M | 0.01% | 699 |
|
|
2024
Q2 | – | Sell |
-4,082
| Closed | -$287K | – | 936 |
|
|
2024
Q1 | $287K | Sell |
4,082
-3,220
| -44% | -$230K | ﹤0.01% | 658 |
|
|
2023
Q4 | $563K | Sell |
7,302
-5,016
| -41% | -$330K | ﹤0.01% | 696 |
|
|
2023
Q3 | $838K | Buy |
12,318
+331
| +3% | +$26.1K | 0.01% | 633 |
|
|
2023
Q2 | $978K | Sell |
11,987
-40,999
| -77% | -$3.3M | 0.01% | 579 |
|
|
2023
Q1 | $3.93M | Buy |
52,986
+47,341
| +839% | +$3.65M | 0.02% | 360 |
|
|
2022
Q4 | $468K | Sell |
5,645
-10,203
| -64% | -$810K | ﹤0.01% | 728 |
|
|
2022
Q3 | $1.13M | Sell |
15,848
-2,876
| -15% | -$249K | 0.01% | 680 |
|
|
2022
Q2 | $1.62M | Buy |
18,724
+4,352
| +30% | +$408K | 0.01% | 720 |
|
|
2022
Q1 | $1.56M | Buy |
14,372
+10,244
| +248% | +$1.06M | 0.01% | 730 |
|
|
2021
Q4 | $534K | Buy |
4,128
+288
| +8% | +$35.3K | ﹤0.01% | 639 |
|
|
2021
Q3 | $465K | Buy |
+3,840
| New | +$467K | ﹤0.01% | 599 |
|
|
2019
Q4 | – | Sell |
-8,440
| Closed | -$413K | – | 567 |
|
|
2019
Q3 | $413K | Buy |
+8,440
| New | +$423K | ﹤0.01% | 290 |
|
|
2019
Q1 | – | Sell |
-49,068
| Closed | -$1.77M | – | 491 |
|
|
2018
Q4 | $1.77M | Buy |
49,068
+41,336
| +535% | +$1.73M | 0.02% | 256 |
|
|
2018
Q3 | $395K | Sell |
7,732
-22,812
| -75% | -$1.01M | ﹤0.01% | 299 |
|
|
2018
Q2 | $1.13M | Sell |
30,544
-3,724
| -11% | -$142K | 0.01% | 238 |
|
|
2018
Q1 | $1.29M | Buy |
+34,268
| New | +$1.21M | 0.01% | 240 |
|
|
2017
Q4 | – | Sell |
-7,820
| Closed | -$236K | – | 319 |
|
|
2017
Q3 | $236K | Sell |
7,820
-11,692
| -60% | -$347K | ﹤0.01% | 278 |
|
|
2017
Q2 | $573K | Buy |
+19,512
| New | +$533K | 0.01% | 245 |
|
|
2016
Q1 | – | Sell |
-9,912
| Closed | -$223K | – | 306 |
|
|
2015
Q4 | $223K | Sell |
9,912
-42,000
| -81% | -$958K | ﹤0.01% | 252 |
|
|
2015
Q3 | $1.2M | Buy |
+51,912
| New | +$1.3M | 0.02% | 224 |
|
|
2015
Q2 | – | Sell |
-17,128
| Closed | -$429K | – | 396 |
|
|
2015
Q1 | $429K | Buy |
17,128
+1,200
| +8% | +$28.5K | ﹤0.01% | 257 |
|
|
2014
Q4 | $368K | Buy |
15,928
+6,728
| +73% | +$154K | ﹤0.01% | 273 |
|
|
2014
Q3 | $215K | Buy |
+9,200
| New | +$216K | ﹤0.01% | 351 |
|
Other funds holding TECH
HI
Bridgewater Associates's TECH Position: Q2 2026 in Review
Bridgewater Associates increased its Bio-Techne (TECH) stake by 348% in Q2 2026, buying an estimated $1.12M and bringing the position to 26,750 shares worth $1.89M. The position accounts for 0.01% of the portfolio, ranked #725.
Bridgewater Associates first reported a position in TECH in Q3 2014 and has held it in 26 quarters since. The position peaked at $3.93M in Q1 2023. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Bridgewater Associates held 26,750 shares of Bio-Techne worth $1.89M as of Q2 2026.
- Bridgewater Associates bought 20,773 Bio-Techne shares in Q2 2026, an estimated $1.12M.
- Bio-Techne made up 0.01% of Bridgewater Associates's portfolio in Q2 2026, its #725 holding.
- Bridgewater Associates first reported a position in Bio-Techne in Q3 2014 and has held it in 26 quarters since.
- Bridgewater Associates's Bio-Techne position peaked at $3.93M in Q1 2023.
- 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.